Semi-Synthetic H2S Releasing Compounds with Antioxidant and Vasorelaxant Properties

Hypertension represents a severe cardiovascular pathology linked to the increase in reactive oxygen species that impair blood vessel function. Herein, we report on the synthesis of hybrid compounds designed to release H2S and incorporate natural or semisynthetic scaffolds capable of activating the Nrf2 pathway. The molecular hybrids enable a multitarget approach concurrently inducing vasorelaxation upon H2S release and mitigating oxidative stress through Nrf2-dependent antioxidant responses via the upregulation of cytoprotective proteins, including HO-1. The itaconate derivative 8b displayed an optimal H2S release in both amperometric and cellular assays. In human aortic smooth muscle cells, compound 8b counteracted ROS production and cytotoxicity in H2O2-injured cells and led to the activation of potassium channels with consequent cell hyperpolarization and vasorelaxation, which was also observed in isolated rat aortic rings. Overall, our findings indicate that simultaneous Nrf2 activation and H2S release hold significant potential as a new therapeutic strategy for the treatment of hypertension.